Luteolin is a flavone. It is one of our more expensive ingredients and is not often included in supplements for this reason.
It is thought to play an important role in thehuman body as an antioxidant, a free radical scavenger, an agent in the prevention of inflammation, a promoter of carbohydrate metabolism, and an immune system modulator.
The characteristics of luteolin are believed to play an important part in the prevention of cancer. Multiple research experiments describe luteolin as a biochemical agent that can dramatically reduce inflammation and the symptoms of septic shock.
Protective Effect of Luteolin on Inflammatory Factor-Mediated Insulin Resistance in 3T3-L1 Adipocytes
Li Ding and Xiaoli Chen
Food Science and Nutrition, University of Minnesota, St. Paul, MN
ABSTRACT
Obesity and insulin resistance have been recently linked toa low-grade chronic inflammatory response characterized by increasedmacrophage infiltration, altered cytokine production, and activationof inflammatory signaling pathway in adipose tissue. Pharmacologicalagents and natural products capable of reducing inflammatoryactivity possess anti-diabetic properties. Luteolin, a naturallyoccurring flavonoid, has been demonstrated to inhibit LPS-inducedTNF release and activation of NF-B pathway in macrophages. However,little is known about the role and mechanism of luteolin onanti-insulin resistance and diabetes. In this study, we investigatedthe role of luteolin in the regulation of inflammatory factor-mediatedinsulin resistance in 3T3-L1 adipocytes. Here we show that luteolintreatment for 24 hrs increased insulin-stimulated glucose uptakein a dose-dependent manner in 3T3-L1 adipocytes. Our resultsalso demonstrated that 24 hour treatment of luteolin enhancedinsulin-stimulated PPAR expression in 3T3-L1 adipocytes. Interestingly,time-dependent serine phosphorylation of insulin receptor substrate1 (IRS-1) by TNF was blocked in 3T3-L1 adipocytes with pretreatmentof luteolin for 30 min. Furthermore, luteolin treatment for24 hrs attenuated LPS-stimulated TNF- secretion from both 3T3-L1preadipocytes and adipocytes. When added to 3T3-L1 cells togetherwith LPS during the entire differentiation process, luteolinantagonized the effect of LPS on the induction of IL-6 geneexpression in 3T3-L1 adipocytes. Thus, our data demonstratethat luteolin plays a protective role in inflammation-mediatedadipocyte dysfunction and insulin resistance.